enVVeno Medical Corporation (NASDAQ:NVNO – Get Free Report) traded up 4.2% during trading on Monday . The company traded as high as $3.51 and last traded at $3.46. 252,688 shares traded hands during trading, an increase of 135% from the average session volume of 107,405 shares. The stock had previously closed at $3.32.
enVVeno Medical Trading Down 4.1 %
The firm has a market cap of $44.12 million, a PE ratio of -1.99 and a beta of 1.21. The business’s 50-day simple moving average is $4.26 and its 200 day simple moving average is $4.83.
enVVeno Medical (NASDAQ:NVNO – Get Free Report) last posted its earnings results on Wednesday, July 31st. The company reported ($0.31) EPS for the quarter. Analysts expect that enVVeno Medical Corporation will post -1.3 earnings per share for the current year.
Institutional Investors Weigh In On enVVeno Medical
About enVVeno Medical
enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Read More
- Five stocks we like better than enVVeno Medical
- Do ETFs Pay Dividends? What You Need to Know
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for enVVeno Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for enVVeno Medical and related companies with MarketBeat.com's FREE daily email newsletter.